BioMed Research International / 2020 / Article / Tab 6

Research Article

In Vitro Evaluation of Curcumin-Encapsulated Chitosan Nanoparticles against Feline Infectious Peritonitis Virus and Pharmacokinetics Study in Cats

Table 6

Log10 copy number of virus and decrement percentages for 3’UTR log10 copy number in samples treated for 24, 48 and 72 h.

Incubation timeTreatment3UTR log10 copy number% log10 copy number decrement

48 hFIPV sampleea
Curcumin 5 μMdb
Cur-CS 5 μMdc
Curcumin 10 μMcdc
Cur-CS 10 μMbcd
Curcumin 20 μMbe
Cur-CS 20 μMaf
72 hFIPV sampleda
Curcumin 5 μMcdb
Cur-CS 5 μMbcdb
Curcumin 10 μMabccd
Cur-CS 10 μMabcd
Curcumin 20 μMabcc
Cur-CS 20 μMad

Data are presented as () and analysed using one-way ANOVA and post hoc Duncan multiple test. For each time interval and parameter, means within a column of determined incubation time (48 and 72 h) with different roman letters were significantly different () from each other. Cur-CS: curcumin-encapsulated chitosan; FIPV: feline infectious peritonitis virus.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.